Next Article in Journal
Screening of Natural Molecules as Adjuvants to Topical Antibiotics to Treat Staphylococcus aureus from Diabetic Foot Ulcer Infections
Next Article in Special Issue
Synergistic Interaction of Caspofungin Combined with Posaconazole against FKS Wild-Type and Mutant Candida auris Planktonic Cells and Biofilms
Previous Article in Journal
Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial Photodynamic Therapy Mediated by Fotenticine and Methylene Blue on Planktonic Growth, Biofilms, and Burn Infections of Acinetobacter baumannii

by
Lívia M. A. Figueiredo-Godoi
1,*,
Maíra T. Garcia
1,
Juliana G. Pinto
2,
Juliana Ferreira-Strixino
2,
Eliseu Gabriel Faustino
1,
Lara Luise Castro Pedroso
1 and
Juliana C. Junqueira
1
1
Institute of Science and Technology (ICT), São Paulo State University (Unesp), São José dos Campos, São Paulo 12245-000, Brazil
2
Photobiology Applied to Health (Photobios), University of Vale of Paraiba/UNIVAP, São José dos Campos, São Paulo 12244-000, Brazil
*
Author to whom correspondence should be addressed.
Antibiotics 2022, 11(5), 619; https://doi.org/10.3390/antibiotics11050619
Submission received: 14 April 2022 / Revised: 2 May 2022 / Accepted: 2 May 2022 / Published: 4 May 2022
(This article belongs to the Special Issue Newer Therapies for Bacterial and Fungal Infections)

Abstract

:
Antimicrobial photodynamic therapy (aPDT) is considered a promising alternative strategy to control Acinetobacter baumannii infections. In this study, we evaluated the action of aPDT mediated by a new photosensitizer derivative from chlorin e-6 (Fotoenticine—FTC) on A. baumannii, comparing its effects with methylene blue (MB). For this, aPDT was applied on A. baumannii in planktonic growth, biofilms, and burn infections in Galleria mellonella. The absorption of FTC and MB by bacterial cells was also evaluated using microscopic and spectrophotometric analysis. The results of planktonic cultures showed that aPDT reduced the number of viable cells compared to the non-treated group for the reference and multidrug-resistant A. baumannii strains. These reductions varied from 1.4 to 2 log10 CFU for FTC and from 2 log10 CFU to total inhibition for MB. In biofilms, aPDT with MB reduced 3.9 log10 CFU of A. baumannii, whereas FTC had no effect on the cell counts. In G. mellonella, only MB-mediated aPDT had antimicrobial activity on burn injuries, increasing the larvae survival by 35%. Both photosensitizers were internalized by bacterial cells, but MB showed a higher absorption compared to FTC. In conclusion, MB had greater efficacy than FTC as a photosensitizer in aPDT against A. baumannii.

1. Introduction

Acinetobacter baumannii is a Gram-negative coccobacillus belonging to the Moraxellaceae family, being among the main opportunistic pathogens associated with nosocomial infections [1,2,3]. The growth of A. baumannii in hospital environments can be attributed to its ability to survive on abiotic surfaces for long time periods and to acquire resistance to many antibiotic classes [1,3,4]. A. baumannii can also colonize the human skin for several months [4], becoming a microbial source for local and systemic infections, mainly in severely ill patients [5]. Due to the high resistance profile, the treatment of A. baumannii infections in debilitated patients has been performed with carbapenems (imipenem and meropenem), which are beta-lactam antibiotics with a wide spectrum of action, considered one of the “last resort” drugs for these patients [6,7,8]. However, in the last decades, there has been a significant increase in the prevalence of carbapenem-resistant A. baumannii (CRAB), placing this microorganism on the antibiotic-resistant priority pathogens list of the World Health Organization (WHO) that urgently needs new therapies [9,10].
In this context, antimicrobial photodynamic therapy (aPDT) has been considered a promising strategy for controlling multi-drug-resistant bacterial infections [11,12,13,14,15,16,17,18]. aPDT consists of the administration of a non-toxic photosensitizer, followed by irradiation by visible light with a wavelength capable of activating the photosensitizer in the presence of molecular oxygen. This reaction results in the formation of reactive oxygen species (ROS) that kill the bacterial cell via a multi-target mode of action instead of the key-lock principle of conventional antibiotics. Since aPDT acts on several molecular targets (proteins, lipids, and nucleic acids), the development of resistance by bacterial cells is very improbable [19]. Seeking to increase the efficacy of aPDT, several photosensitizers have been investigated in the last years, such as phenothiazines, hematoporphyrin derivatives, chlorins, xanthenes, phytolocyanins, and curcumin [20].
Certainly, the phenothiazine methylene blue has been the most used photosensitizer until now. This photosensitizer has received regulatory approval in several countries around the world for use in aPDT. However, phenothiazine dyes are not highly active, and many laboratories have tried to introduce new compounds with better photodynamic properties [21]. Among the new photosensitizers, fotoenticine (FTC), a derivative from chlorin e-6, has shown high photodynamic activity against Gram-positive bacteria [22]. Chlorines are second-generation photosensitizers that belong to the class of tetrapirrolic substances and can be activated by light at 650-800 nm, providing possibilities to treat a variety of infections, including deeper lesions [23]. Although chlorine is a very promising photosensitizer, there are no studies that investigated the use of fotoenticine in the control of A. baumannii.
Besides the identification of new photosensitizers, there is a necessity to thoroughly investigate the action mechanisms of aPDT on in vivo models as its effectiveness also depends on the light penetration in the tissues and the response of the immune system [24]. Seeking to increase the number of in vivo studies and at the same time reduce the use of vertebrate animals, the Galleria mellonella invertebrate model has gained increasing recognition by the scientific community. The success of G. mellonella as a host model can be attributed to the achievement of results comparable to vertebrate animals, ease and low cost of rearing, short life cycle, ethical acceptance, and presence of humoral and cellular immune responses [25,26]. These advantages, associated with the recent sequencing of its genome, make G. mellonella a reliable and very useful in vivo model [27,28]. Previously, our group introduced the use of G. mellonella as a study model for aPDT by injecting both pathogen and photosensitizer into the hemolymph of these animals [24,29,30]. In the present study, we proposed a burn infection model that can be used in aPDT studies focused on bacterial skin infections.
Thus, the objective of this study was to evaluate the effects of aPDT mediated by FTC or methylene blue (MB) on A. baumannii strains, comparing its effects on planktonic growth, biofilms, and experimental local infections in the Galleria mellonella model. In addition, the capacity of both photosensitizers to be absorbed by A. baumannii cells was assessed.

2. Results

2.1. Effects of aPDT on Planktonic Cultures of A. baumannii Strains

For the study of planktonic cultures, three strains of A. baumannii were analyzed, including a reference strain (ATCC 19606) and two multidrug-resistant clinical strains (A1 and A4). Planktonic cultures of all the strains were submitted to six different experimental conditions, forming the following groups: fotoenticine and light (FTC+L+ group), methylene blue and light (MB+L+ group), fotoenticine without irradiation (FTC+L- group), methylene blue without irradiation (MB+L- group), light in the absence of photosensitizer (P-L+ group), and absence of photosensitizer and light (P-L- group). After each treatment condition, the number of viable cells of A. baumannii was determined by counting the number of colony-forming units (CFU).
For all the studied strains, the groups P-L-, FTC+L-, MB+L-, and P-L+ showed similar numbers of viable cells that ranged from 8.3 to 9.0 log10 CFU, with no statistical differences between the groups. These results indicated that the use of FTC or MB in the dark had no toxic effects on A. baumannii cells. On the other hand, the groups treated with aPDT mediated by fotoenticine (FTC+L+) or methylene blue (MB+L+) presented a significant reduction in the number of viable cells compared to the control group (P-L-). For the reference strain, a reduction of 2.0 log10 CFU in the FTC+L+ group and a total inhibition of A. baumannii cells in the MB+L+ group was observed. For the clinical strains, aPDT with FTC (FTC+L+) led to bacterial reductions of 1.4 to 1.9 log10 CFU, while the aPDT with MB (MB+L+) reached reductions of 7.5 to 7.8 log10 CFU (Figure 1). These data showed that all the strains of A. baumannii in planktonic growth were susceptible to aPDT mediated by FTC; however, these effects were less pronounced when compared to aPDT mediated by MB.

2.2. Effects of aPDT on A. baumannii Biofilms

Biofilms of A. baumannii were formed on microtiter plates for 48 h using the reference strain (ATCC 19606). After that, the mature biofilms were divided into 6 groups and submitted to different treatment conditions as described above (P-L-, FTC+L-, MB+L, P-L+, FTC+L+, and MB+L+ groups). The results of viable cells count showed a biofilm formation of approximately 9.3 log10 CFU for the groups not submitted to aPDT, including the P-L-, FTC+L-, MB+L-, and P-L+ groups. Interestingly, the treatment with MB-mediated aPDT caused a significant inhibition in the biofilms, with 3.9 log10 CFU of reduction when compared to the control group (P-L-). However, no inhibition in the number of viable cells was found in the group treated with FTC-mediated therapy (Figure 2), indicating that the A. baumannii biofilms were resistant to the antimicrobial photodynamic effects of FTC.

2.3. Effects of aPDT on Burn Infections in Galleria Mellonella Model

After in vitro studies in planktonic cultures and biofilms of A. baumannii, we moved to an in vivo model of burn infection in G. mellonellla. For this study, G. mellonella larvae were injured with a heated steel instrument in their cuticle to induce a burn wound. Immediately after, this lesion was locally infected with a suspension of A. baumannii ATCC 19606). After 30 min, the photosensitizer was administrated to the lesion. Then, 30 min later, the burn wound was treated with aPDT mediated by FTC or MB. The effects of aPDT on G. mellonella were evaluated for 5 days to determine the survival curve and health index.

2.3.1. Survival Curve

At the end of the experiment (5 days after infection), the larvae not treated with aPDT presented a survival rate of 45%, suggesting that the burn wound model infected by A. baumannii was able to cause a systemic infection that killed the larvae (Figure 3). Promisingly, in the larvae treated with MB-mediated aPDT, the survival rate increased to 80%, showing that this therapy was capable of protecting G. mellonella larvae from subsequent systemic infection. On the other hand, the treatment with FTC-mediated aPDT resulted in only 30% of survival (Figure 4). Thus, considering the parameters employed in this study, only aPDT mediated by MB proved to be effective in treating the infection by A. baumannii in burn wounds in G. mellonella.

2.3.2. Health Index

In addition to the calculation of the survival curve of G. mellonella, the health status of the larvae was also monitored, considering the attributes of movement activity, cocoon formation, and melanization. Regarding the movement activity (Figure 5a), at the end of the experiment, the control group formed by healthy larvae not treated showed 90% of activity, while the burn infection group had 46% of activity. Interestingly, the larvae subjected to burn infection and treated with MB-mediated aPDT maintained 80% of movement activity, but the treatment with FTC-mediated aPDT showed only 22% of activity.
The second attribute analyzed was cocoon formation (Figure 5b). The healthy larvae control group had an index of 80%, with a statistically significant difference (p = 0.0036) in relation to the burn infection not treated group (index of 0%). Larvae subjected to burn infection and treated with aPDT mediated by MB or FTC obtained 10% of cocoon formation, with no significant difference in relation to the burn infection not treated group.
Lastly, in the analysis of melanization (Figure 5c), an index of 10% was found for the healthy larvae control group and 60% for the burn infection not treated group, with a statistically significant difference between them (p = 0.0145). When the larvae with burn infections were treated with aPDT mediated by FTC, the melanization index remained elevated (77%). However, the treatment with aPDT mediated by MB led to a significant reduction of melanization, with an index of 20%.
In summary, the inoculation of A. baumannii in the burn injury reduced the movement activity and cocoon formation of larvae, as well as increased the melanization rate, characterizing the normal infection process. With the application of MB-mediated aPDT, it was possible to increase the movement and cocoon formation of larvae and promote the reduction of the melanization process. Considering all the attributes, the general health index was 9.4 for the healthy larvae group, 4.4 for the burn infection not treated group, 7.4 for burn infection + aPDT with MB group, and 2.8 for burn infection + aPDT with FTC group.

2.4. Absorption of Photosensitizers by the A. baumannii Cells

To investigate the action mechanisms that could be evolved in the different results obtained in relation to the susceptibility of A. baumannii to aPDT mediated by MB or FTC, we added assays to evaluate the photosensitizers’ absorption by bacterial cells. These studies were performed with A. baumannii reference strain (ATCC 19606) in planktonic growth not subjected to aPDT, using a qualitative analysis of confocal microscopy and quantitative analysis of absorbance by spectrophotometry.

2.4.1. Analysis of Confocal Microscopy

In the confocal microscopy images obtained for the A. baumannii treated with MB or FTC, it was possible to observe the morphology of the bacterial cells through the DAPI stained in blue (Figure 6a,d), the presence of the photosensitizers inside the cells in red (Figure 6b,e) and the two overlapping images (Figure 6c,f). In view of these results, it was found that both MB and FTC were capable of internalizing into the A. baumannii planktonic cells.

2.4.2. Test of Absorbance by Spectrophotometry

The quantitative analysis of photosensitizers’ absorption by spectrophotometry confirmed that both MB and FTC were able to penetrate A. baumannii cells (Figure 7). However, the group treated with MB showed higher absorption values (OD = 0.352) than the group treated with FTC (OD = 0.060), with a statistically significant difference between the groups (p = 0.0006). These results suggested that the greater absorption of MB by A. baumannii cells in relation to FTC can be associated with the higher efficacy of MB-mediated aPDT in both in vitro and in vivo studies.

3. Discussion

Antimicrobial photodynamic therapy has shown potential to be used as an adjuvant therapy against bacterial infections; however, its success is dependent on the efficiency of the photosensitizer employed [31]. This study proposed the use of a new chlorine e-6 (FTC) not yet tested as a photosensitizer for aPDT in the control of A. baumannii, comparing its effects with the conventional photosensitizer MB.
First, we verified that aPDT mediated by FTC or MB was able to decrease the A. baumannii cells in planktonic cultures when both reference and multidrug-resistant strains were evaluated. aPDT associated with FTC caused reductions varying from 1.4 to 2 log10 CFU of A. baumannii cells, whereas MB-mediated aPDT reached 2 log10 CFU reduction to total inhibition. These results showed a greater antibacterial effect of MB in aPDT on A. baumannii cells compared to FTC. Sabino et al. [32] evaluated the effect of aPDT with MB on multidrug-resistant strains of Gram-negative and Gram-positive bacteria in planktonic cultures. Using a visible red-light source with an energy density of 40 J/cm2 and irradiation time of 75 s, these authors found more than 5 log10 CFU reduction for strains of A. baumannii, Escherichia coli, Enterococcus faecium, Enterococcus faecalis, and Staphylococcus aureus. For strains of Klebsiella aerogenes, Klebsiella pneumoniae, and Pseudomonas aeruginosa, the same microbial reduction levels occurred with 7 min of irradiation. In another study, Mello et al. [33] applied aPDT mediated by MB on carbapenem-sensitive and carbapenem-resistant A. baumannii isolates. Using a red-light source with 39.5 J/cm2, aPDT decreased the number of A. baumannii planktonic cells for all isolates tested, reaching bacterial reductions ranging from 63 to 88% for susceptible isolates and from 26 to 97% for resistant isolates. These studies confirm that aPDT has antibacterial activity against multidrug-resistant pathogens, including A. baumannii. However, the inhibition level can vary according to the aPDT parameters, species, and strains analyzed. Promisingly, regardless of differences in the light sources, types of photosensitizers, and microbial taxonomy, aPDT shows antibacterial effects against multidrug resistant strains.
Next, aPDT using FTC or MB was tested in biofilms of A. baumannii reference strain. For both photosensitizers, the cells of A. baumannii in biofilms had reduced susceptibility to aPDT compared to its planktonic growth. For the photosensitizer MB, aPDT led to a total inhibition of planktonic cells and a reduction of 3.9 log10 CFU of biofilms. In relation to the photosensitizer FTC, it was found a reduction of 2 log10 CFU of planktonic cells; however, there was no inhibition in biofilms. These results corroborate previous studies that show lower susceptibility of microorganisms enclosed in biofilms than in planktonic states [34,35]. As photosensitizers and oxygen are important components for aPDT reaction, the reduced susceptibility of biofilms may be associated with the limited diffusion of photosensitizers and the hypotoxic microenvironment of biofilms [35].
In both planktonic and biofilm studies, aPDT mediated by MB had higher antimicrobial activity compared to FTC. These results were divergent from the study of Garcia et al. [36], in which MB and two photosensitizers derived from chlorin, Photoditazine® (PDZ) and FTC, were tested on the Streptococcus mutans biofilm. aPDT caused a microbial reduction of 4 log10 CFU with MB, 6 log10 CFU with PDZ, and complete elimination with FTC, indicating that aPDT mediated by photosensitizers derived from chlorin had greater antimicrobial action on S. mutans biofilm than MB. Probably, the differences in the results of FTC-mediated PDT on S. mutans and A. baumannii may be attributed to the cell wall composition of Gram-positive and Gram-negative bacteria. The outer membrane of Gram-negative bacteria, which confers more resistance to antimicrobial drugs, also limits the entry of the photosensitizer into the bacterial cell [19]. Some alternatives to improve the action of photosensitizers on Gram-negative bacteria have been proposed, such as nano-drug delivery systems [35,37]. Among the various nanoparticles available, chitosan nanoparticles show advantages as they are biodegradable, non-toxic, and have a low immunogenic index [38]. Chitosan is a natural cationic biopolymer [39], so the photosensitizer encapsulated by chitosan nanoparticles (with positive charges) may more easily adhere to the cellular wall of the Gram-negative bacteria and consequently exert higher antimicrobial efficacy [38]. Possibly, a nano-drug delivery system can be a strategy to improve the action of FTC-mediated aPDT on A. baumannii.
After in vitro tests, the response of A. baumannii to aPDT mediated by FTC or MB was analyzed using a new in vivo model of burn infection in G. mellonella. Until now, most of the studies with burn infections were developed using murine models. These models usually require many animals and a long period of time [40]. In addition, ethical restrictions that seek to reduce the use of vertebrate animals have stimulated the development of new infection models in invertebrate animals. In this study, we established a burn model in G. mellonella larvae to reproduce superficial infections by A. baumannii that can be locally treated with aPDT. The model was adjusted and established based on the invertebrate burn protocol recently developed by Maslova et al. [41]. After inducing a burn injury on the back of the larvae, the infection was performed with topical administration of A. baumannii suspension. After 30 min, the photosensitizer (FTC or MB) was applied and then irradiated.
The effect of aPDT on burn injuries infected by A. baumannii was analyzed by the survival curve of G. mellonella in 5 days. The group with burn infection not treated showed a mortality rate of 55%. The application of MB-mediated aPDT reduced the mortality rate to 20%. However, FTC-mediated aPDT did not improve the larvae survival. These data showed that only the use of MB in the aPDT provided an improvement in the burn infections in the G. mellonella model. Until now, there are no studies of aPDT application in wound infections in G. mellonella, and our results can be discussed only with studies using murine models. Dai et al. [42] developed a model of burn injuries in mice infected with A. baumannii. The microorganism inoculation was carried out in the burn lesion located on the mouse’s dorsum 5 min after the burn injury. The aPDT consisted of the topical application of the photosensitizer, which was a covalent conjugation of chlorin (e6) to polyethylenimine, after 30 min, 24, and 48 h of infection, followed by illumination with a visible red-light source. aPDT applied immediately after infection resulted in a bacterial reduction of 3 log10 CFU, while applications 1 or 2 days after infections caused reductions of about 1.7 log10 CFU. The authors attributed the success of aPDT due to the conjugation of chlorin e-6 to the cationic polymer polyethylenimine, which can facilitate the penetration of FS in Gram-negative bacteria.
To complement the survival assays of G. mellonella, analysis of additional health attributes, such as movement activity, melanization, and cocoon formation, have been used as important information to assess in more detail the virulence of microorganism and infection development [43]. The movement and cocoon formation indices are attributes of a healthy larva, while the melanization index is related to the immune response to the infection by a pathogen. In the present study, the burn infection reduced the movement activity and cocoon formation of larvae, as well increased the melanization, characterizing an expected infection process. According to Wand et al. [44], more virulent strains of A. baumannii generate higher rates of melanization in G. mellonella larvae, usually occurring after 4 h of infection and signaling a larval death within 24 h. The reduction of cocoon formation may correspond to a sign of disease, but it is important to consider that this attribute is naturally decreased during larval development [45]. With the application of MB-mediated aPDT, it was possible to observe differences in the attributes of the health index. There was an increase in movement activity and cocoon formation and a reduction in the melanization process, indicating an improvement in the health index that resulted in an increase in survival rate.
In summary, aPDT mediated by the FTC or MB was widely explored in this study, using in vitro and in vivo assays. In the in vitro aPDT, FTC was able to reduce the bacterial growth of A. baumannii in planktonic cells, although its effects were less pronounced than MB. Unfortunately, FTC-mediated aPDT was not effective in inhibiting A. baumannii in biofilms and in burn injuries as MB had. Seeking to understand the possible action mechanisms involved in these results, we quantified the capacity of FTC and MB to penetrate the A. baumannii cells. Indeed, the cellular absorption of MB was significantly higher than FTC, suggesting that FTC needs to be conjugated to cationic polymers or encapsulated in drug delivery systems. These strategies can increase the capacity of FTC to penetrate the cell wall of Gram-negative bacteria that possess a double membrane structure containing numerous strongly negatively charged molecules such as LPS [46].
In conclusion, MB as a photosensitizer in the aPDT showed greater antimicrobial efficacy than FTC against A. baumannii strains in both planktonic and biofilm states. MB-mediated aPDT also presented antibacterial activity in burn infections infected by A. baumannii. However, aPDT mediated by FTC was not effective in the treatment of these injuries in G. mellonella.

4. Materials and Methods

4.1. Strains of A. baumannii

Two multidrug-resistant clinical strains of A. baumannii H718 (A1) and HC656 (A4) obtained from the Bioclin Laboratory of São José dos Campos-SP were used. The identification and antibiogram of the strains were determined by the semi-automated MicroSCAN 4 system (Beckman Coulter, Indianapolis, IN, USA), which uses broth microdilution, biochemical reactions, and optical density reading. As a reference, a standard strain of A. baumannii (ATCC 19606) provided by the National Institute for Quality Control in Health (INCQS) of the Oswaldo Cruz Foundation (FIOCRUZ) was used. These strains were stored in frozen stocks in BHI broth containing 20% glycerol at −80 °C. To activate the microorganisms, A. baumannii strains were grown on MacConkey agar culture medium and incubated for 24 h at 37 °C in a bacteriological incubator. Then, colonies characteristic of A. baumannii were transferred to the BHI broth and incubated in a bacteriological incubator at 37 °C for 24 h.

4.2. Preparation of Standardized A. baumannii Suspensions

To perform each experimental test, a standardized suspension of A. baumannii at 108 cels/mL was prepared in a spectrophotometer (B582, Micronal, São Paulo, Brazil) with a wavelength of 600 nm (OD 0.15). In order to confirm the number of bacterial cells used, aliquots of serial dilutions of the inoculum were seeded on plates containing BHI agar for 24 h at 37 °C for CFU/mL counting.

4.3. Photosensitizers and Light Source

The photosensitizers used in the study were fototicine (FTC) and methylene blue (MB). FTC (Nuevas Tecnologías Científicas, Lianera Asturias, Spain) was donated by the company Nuevas Tecnologías Científicas, at a concentration of 6.8 mg/mL. The chemical structure and absorption spectrum of the FTC were described in the study by Terra-Garcia et al. [22]. MB (Sigma-Aldrich, São Paulo, Brazil) was dissolved in sterilized distilled water. Both photosensitizers were sterilized by membrane filtration with pores of 0.22 µm in diameter (MFS, Dublin, Ireland) and stored in dark conditions.
For the study in planktonic cultures, concentrations of 0.1 mg/mL of MB [33] and 0.4 mg/mL of FTC were used. The same concentrations were used in the tests of photosensitizer absorption, as the microorganisms used in these tests were in planktonic growth. As biofilms are more resistant than planktonic cells, in the biofilm assays, the concentrations of photosensitizers were increased, using a concentration of 0.2 mg/mL for MB and 1.2 mg/mL for FTC. For the in vivo model, the concentrations used in the biofilm were maintained.
The light source used was a device composed of 48 LEDs (IrradLed 48, Biopdi, São Carlos, SP, Brazil) with a wavelength of 660 nm (visible red), power density of 42.8 mW/cm2, energy density of 30 J/cm2, and exposure time of 700 s. The study groups carried out were: fotoenticine and light (FTC+L+), methylene blue and light (MB+L+), fotoenticine without irradiation (FTC+L-), methylene blue without irradiation (MB+L-), light in the absence of photosensitizer (P-L+), absence of photosensitizer and light (P-L-).

4.4. aPDT Application on Planktonic Cultures of A. baumannii

The aPDT assay on planktonic cultures of A. baumannii was performed according to the methodology previously described, with some modifications [47]. An aliquot of 100 µL of standardized bacterial suspension and 100 µL of the photosensitizer (MB or FTC) or PBS were added to each well of the 96-well microplates. The microplates were kept for 15 min in agitation (pre-irradiation time) in dark conditions. Subsequently, the LED irradiation was performed according to the parameters already determined. After irradiation, serial dilutions were seeded on BHI agar and incubated for 24 h at 37 °C to count the CFU/mL numbers.

4.5. aPDT Application on A. baumannii Biofilms

Biofilms were formed for 48 h on the bottom of a 24-well microplate using A. baumannii ATCC 19606. Then, the supernatant was aspirated, and the wells were washed twice with PBS. According to the group, 200 µL of the photosensitizer (FTC or MB) or PBS was added to each well. After the pre-irradiation time of 30 min (in an orbital shaker), the biofilms of the groups with the presence of light were subjected to irradiation with the LED device. The whole experiment was carried out in the dark. The biofilm adhered to the bottom of the plate was removed using an ultrasonic homogenizer (Sonopuls HD 2200, Bandelin Electronic, Berlin, Germany) with a power of 7 W for 30 s to disaggregate the biofilm. Serial dilutions were seeded on BHI agar and incubated for 24 h at 37 °C to count the CFU/mL numbers.

4.6. Analysis of the In Vivo Effects of aPDT in a Burn Model of G. mellonella Infected with A. baumannii

4.6.1. G. mellonella Larvae

G. mellonella larvae in their final larval stage were used as a host model. The larvae were obtained from the Invertebrates Laboratory of the Science and Technology Institute-ICT, Unesp São José dos Campos. Each experimental group consisted of 10 larvae with a body weight between 250 and 300 mg. During the experiment, the larvae were not fed. For each assay, a control group composed of larvae with no intervention was included in order to control the quality of rearing larvae.

4.6.2. Induction of Burn Lesion and Infection of A. baumannii in G. mellonella

The induction of burn injury was performed followed the methodology of Maslova et al. [41], with some modifications. The larvae were placed in sterile 24-well plates and kept in a refrigerator at 4 °C until use. The antisepsis of the larval cuticle was performed with 70% ethanol. Subsequently, a steel instrument was heated to redness and applied to the dorsal portion of the larvae for a period of 4 s. For infection, immediately after the burn, 10 µL of a standardized suspension of A. baumannii (ATCC 19606) was locally applied to the lesion.

4.6.3. aPDT in G. mellonella

After 30 min of burn injury and infection with A. baumannii, the larvae were subjected to aPDT [29]. For this, the larvae were locally treated with 10 µL of photosensitizer (FTC or MB) in the burn wound. Larvae remained for 30 min in the dark to provide a dispersion of the photosensitizer at the site. Then, LED irradiation was applied according to the previously defined parameters.
The following groups were included: control group (health larvae not treated), health larvae submitted to light (health larvae treated with light alone), larvae with burn and infection (burn infection not treated), burn and infection submitted to MB-mediated aPDT (burn infection + aPDT with MB), burn and infection submitted to FTC-mediated aPDT (burn infection + aPDT with FTC). Each group consisted of 10 larvae, totaling 50 larvae. Assays were performed in duplicate.

4.6.4. Survival Curve of G. mellonella Larvae

After performing the aPDT, the larvae were placed in 24-well plates, incubated at 37 °C in the dark, and analyzed daily over the course of 120 h (5 days). The number of dead larvae was recorded daily to carry out the survival curve. Larvae that did not show any movement to the touch of a metallic tweezer were considered dead.

4.6.5. G. mellonella Larvae Health Index

Larvae were monitored according to a pathological scoring system proposed by Loh et al. [48] for the following attributes: movement activity, extent of silk production (cocoon formation), melanization, and survival. A score was provided for each attribute (Movement activity: 0, no movement; 1, minimal movement with stimulation; 2, movement with stimulation; 3, movement without stimulation. Cocoon formation: 0, without cocoon; 0.5, incomplete; 1, complete cocoon. Melanization: 0, complete; 1, dark points in brown larva; 2, more than three points in beige larva; 3, less than three points in beige larva; 4, no melanization. Survival: 0, dead larva; 2, alive. All the scores together corresponded to a general index of larva health. The average scores obtained for each analyzed attribute were transformed into percentages of 100% and graphically represented.

4.7. Analysis of Photosensitizer Absorption by A. baumannii Cells

This analysis was performed following the methodology proposed by George, Kishen [49], with some modifications. A. baumannii (ATCC 19606) were cultivated in BHI broth for 24 h. The growth was centrifuged at 5000 rpm for 10 min and washed with distilled water. The optical density of the cultures was adjusted to 108 cells/mL of A. baumannii. After that, 200 μL of this A. baumannii suspension was placed in a microtube containing 200 μL of photosensitizer or distilled water, according to the experimental groups. Microtubes were taken to an orbital incubator at 120 rpm for 15 min at 37 °C. After this period, the A. baumannii cells were centrifuged at 5000 rpm for 10 min and washed twice with distilled water and lysed with 200 μL of 2% Sodium Dodecyl Sulfate (SDS) for 16 h. The absorbance intensity of the supernatant solution after centrifugation (5000 rpm for 10 min) was measured using a spectrophotometer at the wavelength of 600 nm (B582, Micronal, São Paulo, Brasil). The results were recorded in optical density (OD) values.

4.8. Analysis of the Internalization of Photosensitizers by A. baumannii Using Confocal Microscopy

In this assay, 15 mL tubes containing a standardized suspension of A. baumannii were centrifuged, and the supernatant was discarded. A total of 100 µL of photosensitizer (FTC or MB) were added, and the tubes were kept for 15 min at room temperature in the dark. Then, washing with PBS was performed, and the sample was resuspended in 200 µL of 4% formol (Ecibra, São Paulo, SP, Brazil) for fixation. After fixation, 100 µL of this solution were deposited per well in 24-well microplates (Kasvi, São José dos Pinhais, PR, Brazil) containing circular coverslips (Knittel Glass, Germany) previously treated with poly-L-lysine (Sigma-Aldrich, São Paulo, SP, Brazil). The microplates were stored in a refrigerator at 4 °C for 18 h. After this period, 15 µL of prolongTM diamond antifade mount with DAPI (InvitrogenTM, São Paulo, SP, Brazil) were used to mount the coverslips under glass slides. The slides were kept in the dark for 18 h for drying and reading. A confocal microscope LSM 700 (Zeiss, Oberkochen, Germany) was used for analysis with excitation at a length of 405 nm for DAPI, 555 nm for AM, and 488 nm for FTC.

4.9. Statistical Analysis

Planktonic culture tests, biofilms, and health index of G. mellonella larvae were analyzed by the analysis of variance (ANOVA) followed by the Tukey’s test. For the survival curve assays in G. mellonella, the Kaplan–Meier method was used, and the level of significance was calculated using the Log-rank test (Mantel–Cox). In all experimental tests, the GraphPad Prism 9.1 program was used, considering a significance level of 5%.

5. Conclusions

The new photosensitizer derivative from chlorin e-6, fotoenticine, had antimicrobial activity in the aPDT against A. baumannii planktonic cells; however, its effectiveness was lower than aPDT mediated by methylene blue. The antimicrobial effects of fotoenticine and methylene blue occurred when aPDT was applied on reference and multidrug-resistant strains. For both photosensitizers, aPDT showed reduced effectiveness against biofilms compared to planktonic growth. Only methylene blue-mediated aPDT led to significant bacterial reductions of A. baumannii biofilms. These results were expanded to in vivo studies, in which a burn infection model was established in G. mellonella. This model provided a local application of aPDT that resulted in an improvement of the superficial A. baumannii infection when the methylene blue was used as a photosensitizer, confirming the in vitro results. The greatest activity of aPDT mediated by methylene blue was associated with the higher capacity of A. baumannii cells in absorbing the methylene blue in relation to fotoenticine. Overall, these results incite future studies focused on new strategies that can increase the capacity of photosensitizers derivative from chlorin to penetrate the cell wall of Gram-negative bacteria, such as the development of functionalized photosensitizers and delivery systems. Certainly, the burn infection model of G. mellonella can be a useful tool in the discovery of new strategies to overcome the limitations of aPDT on Gram-negative bacteria, such as A. baumannii.

Author Contributions

Conceptualization and supervision, J.C.J.; methodology, L.M.A.F.-G. and J.C.J.; contribute with the methodology, M.T.G. and J.F.-S.; performed the experiments, L.M.A.F.-G., E.G.F. and L.L.C.P.; SEM analysis, J.G.P.; analyzed the data, L.M.A.F.-G. and J.C.J.; writing—review and editing, L.M.A.F.-G. and J.C.J. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Council of Scientific and Technological Development (CNPq), grant number 408369/2018-3. L.M.A.F.G. received a scholarship from the Coordination for the Improvement of Higher Education Personnel (CAPES).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We thank the Nuevas Tecnologías Científicas Company for providing the photosensitizer derivative from chlorin e-6.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Eze, E.C.; Chenia, H.Y.; El Zowalaty, M.E. Acinetobacter Baumannii Biofilms: Effects of Physicochemical Factors, Virulence, Antibiotic Resistance Determinants, Gene Regulation, and Future Antimicrobial Treatments. Infect. Drug Resist. 2018, 11, 2277–2299. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Moubareck, C.A.; Halat, D.H. Insights into Acinetobacter Baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen. Antibiotics 2020, 9, 119. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Nasr, P. Genetics, Epidemiology, and Clinical Manifestations of Multidrug-Resistant Acinetobacter Baumannii. J. Hosp. Infect. 2020, 104, 4–11. [Google Scholar] [CrossRef] [PubMed]
  4. Abdi, S.N.; Ghotaslou, R.; Ganbarov, K.; Mobed, A.; Tanomand, A.; Yousefi, M.; Asgharzadeh, M.; Kafil, H.S. Acinetobacter Baumannii Efflux Pumps and Antibiotic Resistance. Infect. Drug Resist. 2020, 13, 423–434. [Google Scholar] [CrossRef] [Green Version]
  5. Lin, T.-C.; Wu, R.-X.; Chiu, C.-C.; Yang, Y.-S.; Lee, Y.; Lin, J.-C.; Chang, F.-Y. The Clinical and Microbiological Characteristics of Infections in Burn Patients from the Formosa Fun Coast Dust Explosion. J. Microbiol. Immunol. Infect. 2017. [Google Scholar] [CrossRef]
  6. Hsu, L.-Y.; Apisarnthanarak, A.; Khan, E.; Suwantarat, N.; Ghafur, A.; Tambyahb, P.A. Carbapenem-Resistant Acinetobacter Baumannii and Enterobacteriaceae in South and Southeast Asia. Clin. Microbiol. Rev. 2017, 30, 1–22. [Google Scholar] [CrossRef] [Green Version]
  7. Papp-Wallace, K.M.; Endimiani, A.; Taracila, M.A.; Bonomo, R.A. Carbapenems: Past, Present, and Future. Antimicrob. Agents Chemother. 2011, 55, 4943–4960. [Google Scholar] [CrossRef] [Green Version]
  8. Rani, F.M.; Rahman, N.; Ismail, S.; Alattraqchi, A.; Cleary, D.W.; Clarke, S.C.; Yeo, C.C. Acinetobacter Spp. Infections in Malaysia: A Review of Antimicrobial Resistance Trends, Mechanisms and Epidemiology. Front. Microbiol. 2017, 8, 1–13. [Google Scholar] [CrossRef] [Green Version]
  9. Nie, D.; Hu, Y.; Chen, Z.; Li, M.; Hou, Z.; Luo, X.; Mao, X.; Xue, X. Outer Membrane Protein A (OmpA) as a Potential Therapeutic Target for Acinetobacter Baumannii Infection. J. Biomed. Sci. 2020, 27, 1–8. [Google Scholar] [CrossRef] [Green Version]
  10. Wareth, G.; Neubauer, H.; Sprague, L.D. Acinetobacter Baumannii—a Neglected Pathogen in Veterinary and Environmental Health in Germany. Vet. Res. Commun. 2019, 43, 1–6. [Google Scholar] [CrossRef] [Green Version]
  11. Casas, A.; Di Venosa, G.; Hasan, T. Al Batlle Mechanisms of Resistance to Photodynamic Therapy. Curr. Med. Chem. 2011, 18, 2486–2515. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Dai, T.; Huang, Y.-Y.; Hamblin, M.R. Photodynamic Therapy for Localized Infections—State of the Art. NIH Public Access 2010, 6, 170–188. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Dovigo, L.N.; Carmello, J.C.; de Souza Costa, C.A.; Vergani, C.E.; Brunetti, I.L.; Bagnato, V.S.; Pavarina, A.C. Curcumin-Mediated Photodynamic Inactivation of Candida Albicans in a Murine Model of Oral Candidiasis. Med. Mycol. 2013, 51, 243–251. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. François, A.; Salvadori, A.; Bressenot, A.; Bezdetnaya, L.; Guillemin, F.; D’Hallewin, M.A. How to Avoid Local Side Effects of Bladder Photodynamic Therapy: Impact of the Fluence Rate. J. Urol. 2013, 190, 731–736. [Google Scholar] [CrossRef] [PubMed]
  15. Gonzales, F.P.; Maisch, T. Photodynamic Inactivation for Controlling Candida Albicans Infections. Fungal Biol. 2012, 116, 1–10. [Google Scholar] [CrossRef] [PubMed]
  16. Junqueira, J.C.; Fuchs, B.B.; Muhammed, M.; Coleman, J.J.; Suleiman, J.M.; Vilela, S.F.; Costa, A.C.; Rasteiro, V.M.; Jorge, A.O.; Mylonakis, E. Oral Candida Albicans Isolates from HIV-Positive Individuals Have Similar in Vitro Biofilm-Forming Ability and Pathogenicity as Invasive Candida Isolates. BMC Microbiol. 2011, 11, 247. [Google Scholar] [CrossRef] [Green Version]
  17. Junqueira, J.C.; Ribeiro, M.A.; Rossoni, R.D.; Barbosa, J.O.; Querido, S.M.R.; Jorge, A.O.C. Antimicrobial Photodynamic Therapy: Photodynamic Antimicrobial Effects of Malachite Green on Staphylococcus, Enterobacteriaceae, and Candida. Photomed. Laser Surg. 2010, 28, S-67–S-72. [Google Scholar] [CrossRef] [Green Version]
  18. Sahu, A.; Choi, W.I.; Lee, J.H.; Tae, G. Graphene Oxide Mediated Delivery of Methylene Blue for Combined Photodynamic and Photothermal Therapy. Biomaterials 2013, 34, 6239–6248. [Google Scholar] [CrossRef]
  19. Cieplik, F.; Deng, D.; Crielaard, W.; Buchalla, W.; Hellwig, E.; Al-Ahmad, A.; Maisch, T. Antimicrobial Photodynamic Therapy–What We Know and What We Don’t. Crit. Rev. Microbiol. 2018, 44, 571–589. [Google Scholar] [CrossRef] [Green Version]
  20. Bayona, A.M.D.P.; Mroz, P.; Thunshelle, C.; Hamblin, M.R. Design Features for Optimization of Tetrapyrrole Macrocycles as Antimicrobial and Anticancer Photosensitizers. Chem. Biol. Drug Des. 2017, 89, 192–206. [Google Scholar] [CrossRef] [Green Version]
  21. Hamblin, M.R. Antimicrobial Photodynamic Inactivation: A Bright New Technique to Kill Resistant Microbes. Curr. Opin. Microbiol. 2016, 33, 67–73. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Terra-Garcia, M.; de Souza, C.M.; Ferreira Gonçalves, N.M.; Pereira, A.H.C.; de Barros, P.P.; Borges, A.B.; Miyakawa, W.; Strixino, J.F.; Junqueira, J.C. Antimicrobial Effects of Photodynamic Therapy with Fotoenticine on Streptococcus Mutans Isolated from Dental Caries. Photodiagnosis Photodyn. Ther. 2021, 34, 102303. [Google Scholar] [CrossRef] [PubMed]
  23. Silva, R.C.D. Avaliação Da Eficiência Fotodinâmica De Fotossensibilizadores Com Aplicação Em Terapia Fotodinâmica. Doctoral Dissertation, Universidade de São Paulo, São Paulo, Brazil, 2007. [Google Scholar]
  24. Figueiredo-Godoi, L.M.A.; Menezes, R.T.; Carvalho, J.S.; Garcia, M.T.; Segundo, A.G.; Jorge, A.O.C.; Junqueira, J.C. Exploring the Galleria Mellonella Model to Study Antifungal Photodynamic Therapy. Photodiagnosis Photodyn. Ther. 2019, 27, 66–73. [Google Scholar] [CrossRef] [PubMed]
  25. Junqueira, J.C. Galleria Mellonella as a Model Host for Human Pathogens: Recent Studies and New Perspectives. Virulence 2012, 3, 474–476. [Google Scholar] [CrossRef] [Green Version]
  26. Pereira, M.F.; Rossi, C.C.; da Silva, G.C.; Rosa, J.N.; Bazzolli, D.M.S. Galleria Mellonella as an Infection Model: An in-Depth Look at Why It Works and Practical Considerations for Successful Application. Pathog. Dis. 2020, 78, ftaa056. [Google Scholar] [CrossRef]
  27. Wojda, I.; Staniec, B.; Sułek, M.; Kordaczuk, J. The Greater Wax Moth Galleria Mellonella: Biology and Use in Immune Studies. Pathog. Dis. 2020, 78, ftaa057. [Google Scholar] [CrossRef]
  28. Junqueira, J.C.; Mylonakis, E.; Borghi, E. Galleria Mellonella Experimental Model: Advances and Future Directions. Pathog. Dis. 2021, 79, ftab021. [Google Scholar] [CrossRef]
  29. Chibebe Jr, J.; Sabino, C.P.; Tan, X.; Junqueira, J.C.; Wang, Y.; Fuchs, B.B.; Jorge, A.O.C.; Tegos, G.P.; Hamblin, M.R.; Mylonakis, E. Selective Photoinactivation of Candida Albicans in the Non-Vertebrate Host Infection Model Galleria Mellonella. BMC Microbiol. 2013, 13, 217. [Google Scholar] [CrossRef] [Green Version]
  30. Chibebe Junior, J.; Fuchs, B.B.; Sabino, C.P.; Junqueira, J.C.; Jorge, A.O.C.; Ribeiro, M.S.; Gilmore, M.S.; Rice, L.B.; Tegos, G.P.; Hamblin, M.R.; et al. Photodynamic and Antibiotic Therapy Impair the Pathogenesis of Enterococcus Faecium in a Whole Animal Insect Model. PLoS ONE 2013, 8, e55926. [Google Scholar] [CrossRef] [Green Version]
  31. Kou, J.; Dou, D.; Yang, L. Porphyrin Photosensitizers in Photodynamic Therapy and Its Applications. Oncotarget 2017, 8, 81591–81603. [Google Scholar] [CrossRef] [Green Version]
  32. Sabino, C.P.; Wainwright, M.; Ribeiro, M.; Sellera, F.P.; dos Anjos, C.; Baptista, M.D.S.; Lincopan, N. Global Priority Multidrug-Resistant Pathogens Do Not Resist Photodynamic Therapy. J. Photochem. Photobiol. B Biol. 2020, 208, 111893. [Google Scholar] [CrossRef] [PubMed]
  33. Mello, M.M.; de Barros, P.P.; de Bernardes, R.C.; Alves, S.R.; Ramanzini, N.P.; Figueiredo-Godoi, L.M.A.; Prado, A.C.C.; Jorge, A.O.C.; Junqueira, J.C. Antimicrobial Photodynamic Therapy against Clinical Isolates of Carbapenem-Susceptible and Carbapenem-Resistant Acinetobacter Baumannii. Lasers Med. Sci. 2019, 34, 1755–1761. [Google Scholar] [CrossRef] [PubMed]
  34. Sin, J.H.; Walsh, L.J.; Figueredo, C.M.; George, R. Evaluation of Effectiveness of Photosensitizers Used in Laser Endodontics Disinfection: A Systematic Review. Transl. Biophotonics 2021, 3. [Google Scholar] [CrossRef]
  35. Wang, Y.; Xu, Y.; Guo, X.; Wang, L.; Zeng, J.; Qiu, H.; Tan, Y.; Chen, D.; Zhao, H.; Gu, Y. Enhanced Antimicrobial Activity through the Combination of Antimicrobial Photodynamic Therapy and Low-Frequency Ultrasonic Irradiation. Adv. Drug Deliv. Rev. 2022, 183, 114168. [Google Scholar] [CrossRef] [PubMed]
  36. Garcia, M.; Pereira, A.H.C.; Figueiredo-Godoi, L.M.A.; Jorge, A.O.C.; Strixino, J.F.; Junqueira, J.C. Photodynamic Therapy Mediated by Chlorin-Type Photosensitizers against Streptococcus Mutans Biofilms. Photodiagnosis Photodyn. Ther. 2018, 24, 256–261. [Google Scholar] [CrossRef] [PubMed]
  37. Krajczewski, J.; Rucińska, K.; Townley, H.E.; Kudelski, A. Role of Various Nanoparticles in Photodynamic Therapy and Detection Methods of Singlet Oxygen. Photodiagnosis Photodyn. Ther. 2019, 26, 162–178. [Google Scholar] [CrossRef] [PubMed]
  38. Pourhajibagher, M.; Hosseini, N.; Boluki, E.; Chiniforush, N.; Bahador, A. Photoelimination Potential of Chitosan NanoparticlesIndocyanine Green Complex Against the Biological Activities of Acinetobacter Baumannii Strains: A Preliminary In Vitro Study in Burn Wound Infections. J. Lasers Med. Sci. 2020, 11, 187–192. [Google Scholar] [CrossRef] [Green Version]
  39. Fekrirad, Z.; Darabpour, E.; Kashef, N. Eradication of Acinetobacter Baumannii Planktonic and Biofilm Cells Through Erythrosine-Mediated Photodynamic Inactivation Augmented by Acetic Acid and Chitosan. Curr. Microbiol. 2021, 78, 879–886. [Google Scholar] [CrossRef]
  40. Sperandio, F.; Huang, Y.-Y.; Hamblin, M. Antimicrobial Photodynamic Therapy to Kill Gram-Negative Bacteria. Recent Pat. Anti-Infect. Drug Discov. 2013, 8, 108–120. [Google Scholar] [CrossRef] [Green Version]
  41. Maslova, E.; Shi, Y.; Sjöberg, F.; Azevedo, H.S.; Wareham, D.W.; McCarthy, R.R. An Invertebrate Burn Wound Model That Recapitulates the Hallmarks of Burn Trauma and Infection Seen in Mammalian Models. Front. Microbiol. 2020, 11, 1–8. [Google Scholar] [CrossRef]
  42. Dai, T.; Tegos, G.P.; Lu, Z.; Huang, L.; Zhiyentayev, T.; Franklin, M.J.; Baer, D.G.; Hamblin, M.R. Photodynamic Therapy for Acinetobacter Baumannii Burn Infections in Mice. Antimicrob. Agents Chemother. 2009, 53, 3929–3934. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Romera, D.; Aguilera-Correa, J.-J.; García-Coca, M.; Mahillo-Fernández, I.; Viñuela-Sandoval, L.; García-Rodríguez, J.; Esteban, J. The Galleria Mellonella Infection Model as a System to Investigate the Virulence of Candida Auris Strains. Pathog. Dis. 2020, 78, 51–87. [Google Scholar] [CrossRef] [PubMed]
  44. Wand, M.E.; Bock, L.J.; Turton, J.F.; Nugent, P.G.; Sutton, J.M. Acinetobacter Baumannii Virulence Is Enhanced in Galleria Mellonella Following Biofilm Adaptation. J. Med. Microbiol. 2012, 61, 470–477. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Jorjão, A.L.; Oliveira, L.D.; Scorzoni, L.; Figueiredo-Godoi, L.M.A.; Cristina, A.; Prata, M.; Jorge, A.O.C.; Junqueira, J.C. From Moths to Caterpillars: Ideal Conditions for Galleria Mellonella Rearing for in Vivo Microbiological Studies. Virulence 2018, 9, 383–389. [Google Scholar] [CrossRef] [Green Version]
  46. Hu, X.; Huang, Y.-Y.; Wang, Y.; Wang, X.; Hamblin, M.R. Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections. Front. Microbiol. 2018, 9, 1299. [Google Scholar] [CrossRef] [Green Version]
  47. Costa, A.C.B.P.; Chibebe Junior, J.; Pereira, C.A.; Machado, A.K.D.S.; Beltrame Junior, M.; Junqueira, J.C.; Jorge, A.O.C. Susceptibility of Planktonic Cultures of Streptococcus Mutans to Photodynamic Therapy with a Light-Emitting Diode. Braz. Oral Res. 2010, 24, 413–418. [Google Scholar] [CrossRef]
  48. Loh, J.M.; Adenwalla, N.; Wiles, S.; Proft, T. Galleria Mellonella Larvae as an Infection Model for Group A Streptococcus. Virulence 2013, 4, 419–428. [Google Scholar] [CrossRef] [Green Version]
  49. George, S.; Kishen, A. Photophysical, Photochemical, and Photobiological Characterization of Methylene Blue Formulations for Light-Activated Root Canal Disinfection. J. Biomed. Opt. 2007, 12, 034029. [Google Scholar] [CrossRef]
Figure 1. Means and standard deviation of viable cells of A. baumannii (log10 CFU) in planktonic growth for the following groups: absence of photosensitizer and light (P-L-), FTC without light (FTC+L-), MB without light (MB+L-), absence of photosensitizer with light (P-L+), FTC with light (FTC+L+), and MB with light (MB+L+). (a) A. baumannii reference strain (ATCC 19606). (b) A. baumannii A2 clinical strain. (c) A. baumannii A4 clinical strain. ANOVA and Tukey test: different letters represent statistical difference between the groups (p ≤ 0.05).
Figure 1. Means and standard deviation of viable cells of A. baumannii (log10 CFU) in planktonic growth for the following groups: absence of photosensitizer and light (P-L-), FTC without light (FTC+L-), MB without light (MB+L-), absence of photosensitizer with light (P-L+), FTC with light (FTC+L+), and MB with light (MB+L+). (a) A. baumannii reference strain (ATCC 19606). (b) A. baumannii A2 clinical strain. (c) A. baumannii A4 clinical strain. ANOVA and Tukey test: different letters represent statistical difference between the groups (p ≤ 0.05).
Antibiotics 11 00619 g001
Figure 2. Means and standard deviation of viable cells of A. baumannii (log10 CFU) in biofilms for the following groups: absence of photosensitizer and light (P-L-), FTC without light (FTC+L-), MB without light (MB+L-), absence of photosensitizer with light (P-L+), FTC with light (FTC+L+), and MB with light (MB+L+). (a) Experiment performed to test the photosensitizer MB. (b) Experiment performed to test the photosensitizer FTC. ANOVA and Tukey test: different letters represent statistical difference between the groups (p ≤ 0.05).
Figure 2. Means and standard deviation of viable cells of A. baumannii (log10 CFU) in biofilms for the following groups: absence of photosensitizer and light (P-L-), FTC without light (FTC+L-), MB without light (MB+L-), absence of photosensitizer with light (P-L+), FTC with light (FTC+L+), and MB with light (MB+L+). (a) Experiment performed to test the photosensitizer MB. (b) Experiment performed to test the photosensitizer FTC. ANOVA and Tukey test: different letters represent statistical difference between the groups (p ≤ 0.05).
Antibiotics 11 00619 g002
Figure 3. Burn infection model in G. mellonella. Larvae were injured with a heated steel instrument in their cuticle (a), resulting in a burn lesion (b). After larvae were locally infected with a suspension of A. baumannii (c), it was possible to observe the progression of systemic infection (d).
Figure 3. Burn infection model in G. mellonella. Larvae were injured with a heated steel instrument in their cuticle (a), resulting in a burn lesion (b). After larvae were locally infected with a suspension of A. baumannii (c), it was possible to observe the progression of systemic infection (d).
Antibiotics 11 00619 g003
Figure 4. Survival curve of G. mellonella obtained in the following groups: healthy larvae not treated, healthy larvae treated with light alone, larvae with burn infected by A. baumannii and not treated, larvae with burn infected by A. baumannii and treated with MB-mediated aPDT, and larvae with burn infected by A. baumannii and treated with FTC-mediated aPDT. Comparison of survival curves by Log-rank test: no statistically significant differences were found for the groups “burn infection + aPDT with MB” (p = 0.1827) and “burn infection + aPDT with FTC” (p = 0.5780) in relation to “burn infection not treated”.
Figure 4. Survival curve of G. mellonella obtained in the following groups: healthy larvae not treated, healthy larvae treated with light alone, larvae with burn infected by A. baumannii and not treated, larvae with burn infected by A. baumannii and treated with MB-mediated aPDT, and larvae with burn infected by A. baumannii and treated with FTC-mediated aPDT. Comparison of survival curves by Log-rank test: no statistically significant differences were found for the groups “burn infection + aPDT with MB” (p = 0.1827) and “burn infection + aPDT with FTC” (p = 0.5780) in relation to “burn infection not treated”.
Antibiotics 11 00619 g004
Figure 5. Means of scores obtained in the health index analysis for the groups: healthy larvae not treated (control group), burn infection not treated group, burn infection + aPDT with MB group, and burn infection + aPDT with FTC group. ANOVA and Tukey test (p ≤ 0.05). (a) Movement activity: burn infection not treated group compared to burn infection + aPDT with MB group (p = 0.2668) and burn infection + aPDT with FTC group (p = 0.2321). (b) Cocoon formation: burn infection not treated group compared to burn infection + aPDT with MB group (p = 0.8055) and burn infection + aPDT with FTC group (p = 0.9989). (c) Melanization: burn infection not treated group compared to burn infection + aPDT with MB group (p = 0.1713) and burn infection + aPDT with FTC group (p = 0.6183).
Figure 5. Means of scores obtained in the health index analysis for the groups: healthy larvae not treated (control group), burn infection not treated group, burn infection + aPDT with MB group, and burn infection + aPDT with FTC group. ANOVA and Tukey test (p ≤ 0.05). (a) Movement activity: burn infection not treated group compared to burn infection + aPDT with MB group (p = 0.2668) and burn infection + aPDT with FTC group (p = 0.2321). (b) Cocoon formation: burn infection not treated group compared to burn infection + aPDT with MB group (p = 0.8055) and burn infection + aPDT with FTC group (p = 0.9989). (c) Melanization: burn infection not treated group compared to burn infection + aPDT with MB group (p = 0.1713) and burn infection + aPDT with FTC group (p = 0.6183).
Antibiotics 11 00619 g005
Figure 6. Confocal microscopy of MB and FTC internalization by A. baumannii planktonic cells. (a,d) A. baumannii cells with DAPI stained; Internalization of MB (b) and FTC (e) by A. baumannii cells; The two overlapping images for MB (c) and FCT (f).
Figure 6. Confocal microscopy of MB and FTC internalization by A. baumannii planktonic cells. (a,d) A. baumannii cells with DAPI stained; Internalization of MB (b) and FTC (e) by A. baumannii cells; The two overlapping images for MB (c) and FCT (f).
Antibiotics 11 00619 g006
Figure 7. Means and SD of absorbance values (600 nm) in optical density values showing the absorption of MB and FTC by the A. baumannii cells (ATCC 19606). (Water) A. baumannii in sterile distilled water only; (MB) A. baumannii treated with MB; (FTC) A. baumannii treated with FTC.
Figure 7. Means and SD of absorbance values (600 nm) in optical density values showing the absorption of MB and FTC by the A. baumannii cells (ATCC 19606). (Water) A. baumannii in sterile distilled water only; (MB) A. baumannii treated with MB; (FTC) A. baumannii treated with FTC.
Antibiotics 11 00619 g007
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Figueiredo-Godoi, L.M.A.; Garcia, M.T.; Pinto, J.G.; Ferreira-Strixino, J.; Faustino, E.G.; Pedroso, L.L.C.; Junqueira, J.C. Antimicrobial Photodynamic Therapy Mediated by Fotenticine and Methylene Blue on Planktonic Growth, Biofilms, and Burn Infections of Acinetobacter baumannii. Antibiotics 2022, 11, 619. https://doi.org/10.3390/antibiotics11050619

AMA Style

Figueiredo-Godoi LMA, Garcia MT, Pinto JG, Ferreira-Strixino J, Faustino EG, Pedroso LLC, Junqueira JC. Antimicrobial Photodynamic Therapy Mediated by Fotenticine and Methylene Blue on Planktonic Growth, Biofilms, and Burn Infections of Acinetobacter baumannii. Antibiotics. 2022; 11(5):619. https://doi.org/10.3390/antibiotics11050619

Chicago/Turabian Style

Figueiredo-Godoi, Lívia M. A., Maíra T. Garcia, Juliana G. Pinto, Juliana Ferreira-Strixino, Eliseu Gabriel Faustino, Lara Luise Castro Pedroso, and Juliana C. Junqueira. 2022. "Antimicrobial Photodynamic Therapy Mediated by Fotenticine and Methylene Blue on Planktonic Growth, Biofilms, and Burn Infections of Acinetobacter baumannii" Antibiotics 11, no. 5: 619. https://doi.org/10.3390/antibiotics11050619

APA Style

Figueiredo-Godoi, L. M. A., Garcia, M. T., Pinto, J. G., Ferreira-Strixino, J., Faustino, E. G., Pedroso, L. L. C., & Junqueira, J. C. (2022). Antimicrobial Photodynamic Therapy Mediated by Fotenticine and Methylene Blue on Planktonic Growth, Biofilms, and Burn Infections of Acinetobacter baumannii. Antibiotics, 11(5), 619. https://doi.org/10.3390/antibiotics11050619

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop